When Myeloma Patients Relapse After Becoming Refractory to Lenalidomide
BY PAUL KLEUTGHEN Several studies have been published recently that present the benefits of MM therapy that includes lenalidomide. A…
An Update on Primary Plasma Cell Leukemia Treatment Options
BY PAUL KLEUTGHEN For the 150, or so, with primary Plasma Cell Leukemia… An interesting article was recently published in…
Our Next Show: Liquid Biopsies with Irene Ghobrial, MD and Salomon Manier, MD, PhD, Dana Farber, Wednesday, Sept 27 @ Noon EST
Wednesday, Sept 27, 2017 @ 9 am Pacific, 10 am Mountain, 11 am Central, Noon Eastern Call In by Phone…
Full Show: Sugar’s Secret Cloak for Multiple Myeloma Cells with Michael O’Dwyer, NUI Galway
Michael O’Dwyer, MD National University of Ireland Galway Interview Date: August 25, 2017 Summary Why does multiple myeloma become resistant…
Our Next Show: Liquid Biopsies with Irene Ghobrial, MD and Salomon Manier, MD, PhD, Dana Farber, Wednesday, Sept 27 @ Noon EST
Wednesday, Sept 27, 2017 @ 9 am Pacific, 10 am Mountain, 11 am Central, Noon Eastern Call In by Phone…
Clinical Trial: New Multiple Myeloma BCMA CAR T Cell Trial from Poseida Therapeutics Opens at Sarah Cannon and MD Anderson
A new CAR T Cell Trial is underway this month at Sarah Cannon in Nashville, TN and at MD Anderson…
UPCOMING MYELOMA CROWD EVENTS
October 14, 2017, Myeloma Crowd Round Tables: Phoenix, AZ
Myeloma Crowd Round Tables are day-long meetings that provide patients and caregivers updated information so…
September 30, 2017, Myeloma Crowd Round Tables: New York, NY
Myeloma Crowd Round Tables are day-long meetings that provide patients and caregivers updated information so…
September 23, 2017, Myeloma Crowd Round Tables: Detroit, Michigan
Myeloma Crowd Round Tables are day-long meetings that provide patients and caregivers updated information so…
MYELOMA CROWD RESEARCH CAMPAIGNS
Myeloma Crowd Research Initiative (MCRI) Funds Two Immunotherapy Projects
The Myeloma Crowd Initiative selected two proposals it has selected for the MCRI crowdsourcing and…
Continuing the Fight for a Myeloma Cure: Dr. Tricot and Dr. Zhan’s Research to Improve Outcomes for High-Risk Myeloma Patients
Guido Tricot, MD, PhD has devotedly attended to thousands of multiple myeloma patients for over…
Thanks to our site sponsors:
